Gene · 4157
Papers3,724
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 3,724
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chromosome X-wide Analysis of Positive Selection in Human Populations: Common and Private Signals of Selection and its Impact on Inactivated Genes and Enhancers. | Front Genet | 2021 | 34646300 | PubTator, text mining | PubMed |
| An Insight into Sesamolin: Physicochemical Properties, Pharmacological Activities, and Future Research Prospects. | Molecules | 2021 | 34641392 | PubTator, text mining | PubMed |
| Evaluating Whether Radiofrequency Irradiation Attenuated UV-B-Induced Skin Pigmentation by Increasing Melanosomal Autophagy and Decreasing Melanin Synthesis. | Int J Mol Sci | 2021 | 34639063 | PubTator, text mining | PubMed |
| Etiologies of Melanoma Development and Prevention Measures: A Review of the Current Evidence. | Cancers (Basel) | 2021 | 34638397 | PubTator, text mining | PubMed |
| Positive association between actinic keratosis and internal malignancies: a nationwide population-based cohort study. | Sci Rep | 2021 | 34611257 | PubTator, text mining | PubMed |
| Regulation of EGFR signalling by palmitoylation and its role in tumorigenesis. | Open Biol | 2021 | 34610265 | PubTator, text mining | PubMed |
| Identification of Sitogluside as a Potential Skin-Pigmentation-Reducing Agent through Network Pharmacology. | Oxid Med Cell Longev | 2021 | 34603597 | PubTator, text mining | PubMed |
| Development of a Multi-Target Strategy for the Treatment of Vitiligo via Machine Learning and Network Analysis Methods. | Front Pharmacol | 2021 | 34603063 | PubTator, text mining | PubMed |
| Fingolimod and Diabetic Retinopathy: A Drug Repurposing Study. | Front Pharmacol | 2021 | 34603029 | PubTator, text mining | PubMed |
| Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence. | J Immunother Cancer | 2021 | 34599031 | PubTator, text mining | PubMed |
Functional Mixture-Based Positional Scan Identifies a Library of Antagonist Tetrapeptide Sequences (LAtTeS) with Nanomolar Potency for the Melanocortin-4 Receptor and Equipotent with the Endogenous AGRP(86-132) Antagonist. | J Med Chem | 2021 | 34592820 | PubTator, text mining | PubMed |
| Human Chorionic Gonadotropin and Related Peptides: Candidate Anti-Inflammatory Therapy in Early Stages of Sepsis. | Front Immunol | 2021 | 34589085 | PubTator, text mining | PubMed |
| Influence of Selective Melanocortin-4 Receptor Antagonist HS014 on Hypersensitivity After Nervous System Injuries in a Model of Rat Neuropathic Pain: A Narrative Review of the Literature. | Cureus | 2021 | 34584810 | PubTator, text mining | PubMed |
| Contribution of rare variant associations to neurodegenerative disease presentation. | NPJ Genom Med | 2021 | 34584092 | PubTator, text mining | PubMed |
| Genetic Variants and Somatic Alterations Associated with MITF-E318K Germline Mutation in Melanoma Patients. | Genes (Basel) | 2021 | 34573422 | PubTator, text mining | PubMed |
| Molecular Markers and Targets in Melanoma. | Cells | 2021 | 34571969 | PubTator, text mining | PubMed |
| A signature of Neanderthal introgression on molecular mechanisms of environmental responses. | PLoS Genet | 2021 | 34570765 | PubTator, text mining | PubMed |
| Combining histone deacetylase inhibitors (HDACis) with other therapies for cancer therapy. | Eur J Med Chem | 2021 | 34562854 | PubTator, text mining | PubMed |
| Structures of active melanocortin-4 receptor-Gs-protein complexes with NDP-α-MSH and setmelanotide. | Cell Res | 2021 | 34561620 | PubTator, text mining | PubMed |
| GenNet framework: interpretable deep learning for predicting phenotypes from genetic data. | Commun Biol | 2021 | 34535759 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4157/papers?page=45